Is short duration trastuzumab adequate adjuvant therapy for HER-2 overexpressing breast cancers?
No Thumbnail Available
Date
2006-09-06
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
Goyal L, Gupta S. Is short duration trastuzumab adequate adjuvant therapy for HER-2 overexpressing breast cancers? National Medical Journal of India. 2006 Sep-Oct; 19(5): 264-5